CING · NASDAQ · Biotechnology

Cingulate (CING)

Develops once-daily ADHD medicines using a multi-core timed-release platform.

$5.16
At close+0.05 (+0.98%)

Breakdown13F · 13D/G · Form 4

Institutions27 holders · as of Mar 31, 20268.17%1.19M shares
Insiders7 holders · as of Jun 8, 20261.78%259.3K shares
Strategic holders1 holder · as of Mar 26, 202626.52%3.86M shares
Otherremainder63.53%9.24M shares

14.54M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Falcon Creek Capital Advisor LLCStrategic
26.52%3.86M13Dfiled Mar 26, 2026
Vanguard Capital Management LLCInstitution
2.12%308,96713Fas of Mar 31, 2026
Kestra Advisory Services, LLCInstitution
0.96%140,00013Fas of Mar 31, 2026
Peter J. WerthInsiderdirector
0.81%117,449Form 4filed Feb 10, 2026
Geode Capital Management, LLCInstitution
0.70%101,37313Fas of Mar 31, 2026
Thomas Jeffrey HargrovesInsiderdirector
0.67%97,468Form 4filed Jun 8, 2026
Marshall Wace, LLPInstitution
0.64%92,93413Fas of Mar 31, 2026
Jane Street Group, LLCInstitution
0.62%90,86713Fas of Mar 31, 2026
XTX Topco LtdInstitution
0.37%53,50313Fas of Mar 31, 2026
BCV Asset Management Inc.Institution
0.35%51,20013Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.34%50,07413Fas of Mar 31, 2026
Quadrature Capital LtdInstitution
0.24%34,83913Fas of Mar 31, 2026
HRT Financial LPInstitution
0.23%33,14413Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
0.22%31,88813Fas of Mar 31, 2026
State Street CorpInstitution
0.19%27,58813Fas of Mar 31, 2026
Virtu Financial LLCInstitution
0.19%27,52813Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.16%23,26913Fas of Mar 31, 2026
Northern Trust CorpInstitution
0.15%22,27213Fas of Mar 31, 2026
Prospera Financial Services IncInstitution
0.15%21,80013Fas of Mar 31, 2026
Chicago Partners Investment Group LLCInstitution
0.13%18,75013Fas of Mar 31, 2026
Soltis Investment Advisors LLCInstitution
0.11%16,44213Fas of Mar 31, 2026
Shane J. SchafferInsiderdirector, officer: Chief Executive Officer
0.10%14,251Form 4filed Mar 11, 2026
Jennifer L. CallahanInsiderofficer: EVP and CFO
0.10%13,961Form 4filed Mar 11, 2026
Mariner, LLCInstitution
0.09%12,93013Fas of Mar 31, 2026
UBS Group AGInstitution
0.08%11,03313Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

27 holders · 1.19M shares · 14 new positions · 21 increased · 3 reduced · 5 closed

HolderShares% outstandingChg q/qFiled
Vanguard Capital Management LLC309.0K2.12%+309.0KnewMay 15, 2026
Kestra Advisory Services, LLC140.0K0.96%+18.0KApr 30, 2026
Geode Capital Management, LLC101.4K0.70%+40.3KMay 15, 2026
Marshall Wace, LLP92.9K0.64%+92.9KnewMay 15, 2026
Jane Street Group, LLC90.9K0.62%+90.9KnewMay 12, 2026
XTX Topco Ltd53.5K0.37%+32.8KMay 15, 2026
BCV Asset Management Inc.51.2K0.35%+51.2KnewMay 8, 2026
Vanguard Fiduciary Trust Co50.1K0.34%+50.1KnewMay 8, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Falcon Creek Capital Advisor LLCincl. Falcon Creek Technology Fund I, LP, Ginkgo Capital Global Fund SPC - Xtalpi AI Fund SP28.50%3.86M13DMar 26, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Feb 13, 2026
Thomas Jeffrey Hargrovesdirector
Purchase · 2 lots175,097$5.04175,289
Feb 6, 2026
Matthew Bramsofficer: EVP and Chief Medical Officer
Purchase · 2 lots3,502$5.046,212
Feb 6, 2026
Shane J. Schafferdirector, officer: Chief Executive Officer
Purchase · 2 lots12,256$5.0415,622
Feb 6, 2026
Jennifer L. Callahanofficer: SVP and CFO
Purchase · 2 lots8,755$5.048,950
Feb 6, 2026
Peter J. Werthdirector
Purchase · 2 lots35,019$5.04133,013

CongressHouse and Senate disclosures

Not reported.